Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Author(s)
Type
Journal Article
Abstract
BACKGROUND: Mosaic attenuation on CT has been identified in international guidelines as an important diagnostic feature of fibrotic hypersensitivity pneumonitis (FHP) as opposed to idiopathic pulmonary fibrosis (IPF). However, mosaic attenuation (MA) comprises several different radiological signs (low density lobules [LDL], preserved lobules [PL], air trapping [AT] and the so-called "headcheese sign") which may have differing diagnostic utility. Furthermore, the extent of MA required to distinguish these two diagnoses is uncertain, and thresholds of MA from international guidelines have not been validated. METHODS: Inspiratory and expiratory CTs were evaluated by two readers in 102 patients (IPF n=57; FHP n=45) using a semiquantitative scoring system for MA. Findings were validated in an external cohort from a secondary referral institution (IPF n=34; FHP n=28). RESULTS: LDL and AT were a frequent finding in IPF, present in up to 51% of patients. A requirement for increasing extent of LDL and AT based on guidelines (ATS and Fleischner Society) was associated with increased specificity for the diagnosis of FHP (0.96 and 0.98, respectively) but reduced sensitivity (0.16 and 0.20 respectively). The "headcheese" sign was found to be highly specific (0.93), and moderately sensitive (0.49) for a high confidence diagnosis of FHP. The high specificity of the headcheese sign was maintained in the validation cohort, and when patients with other CT features of FHP were excluded. CONCLUSION: MA is a frequent finding in IPF. However, the headcheese sign can be confidently considered as being inconsistent with a diagnosis of IPF and specific for FHP.
Date Issued
2019-06-04
Date Acceptance
2019-04-21
Citation
European Respiratory Journal, 2019, 54 (1), pp.1-10
ISSN
0903-1936
Publisher
European Respiratory Society
Start Page
1
End Page
10
Journal / Book Title
European Respiratory Journal
Volume
54
Issue
1
Copyright Statement
© 2019 ERS.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31164428
PII: 13993003.00531-2019
Subjects
Science & Technology
Life Sciences & Biomedicine
Respiratory System
DIAGNOSTIC-CRITERIA
FLEISCHNER-SOCIETY
STATEMENT
SMOKING
Respiratory System
11 Medical and Health Sciences
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2019-07-25